LabCorp
North America, North Carolina, United States, Burlington
Description
Labcorp specializes in providing physicians with laboratory tests.
Investor Profile
LabCorp has backed more than 53 startups, with 9 new investments in the last 12 months alone. The firm has led 9 rounds, about 17% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.
Stage Focus
- Series B (32%)
- Series A (28%)
- Series C (13%)
- Series Unknown (11%)
- Seed (6%)
- Corporate Round (4%)
- Series G (2%)
- Series F (2%)
- Series D (2%)
Country Focus
- United States (96%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (2%)
Industry Focus
- Health Care
- Biotechnology
- Health Diagnostics
- Medical
- Personal Health
- Life Science
- Software
- Hospital
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
